Author

C. Guerin-Charbonnel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:chromatin & epigenetic regulation· 2 Assay:DNA methylation· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

F. Magrangeas· 3 shared L. Campion· 3 shared P. Moreau· 3 shared S. Minvielle· 3 shared C. Herrmann· 2 shared E. Douillard· 2 shared H. Avet-Loiseau· 2 shared J. Derrien· 2 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

F. Magrangeas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 6, 2021

Chromatin accessibility combined with enhancer clusters activation mediates heterogeneous response to dexamethasone in myeloma cells

V. GABORIT, J. CRUARD, C. Guerin-Charbonnel…·S. Minvielle

The paper investigates how chromatin accessibility and enhancer clusters mediate heterogeneous responses to dexamethasone in myeloma cells, showing epigenomic changes linked to transcriptional heterogeneity.

DOI 10.1101/2021.09.06.459068

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 1, 2020

The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability

J. Derrien, C. Guerin-Charbonnel, V. Gaborit…·S. Minvielle

This study examines DNA methylation heterogeneity in multiple myeloma, linking it to transcriptomic variability and poor patient outcomes through epigenetic and structural changes.

DOI 10.1101/2020.10.01.321943

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivOct 16, 2019

DNA hydroxymethylation reveals transcription regulation networks and prognostic signatures in multiple myeloma

J.-B. Alberge, F. Magrangeas, M. Wagner…·A. A. Serandour

This study analyzes DNA hydroxymethylation in multiple myeloma to identify regulation networks and prognostic signatures associated with disease progression and survival.

DOI 10.1186/s13148-020-00953-y

humanDNA methylation

𝕏 PostBluesky